Argenx
ARGX
#406
Rank
NZ$107.48 B
Marketcap
NZ$1,728
Share price
-0.21%
Change (1 day)
37.08%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

We have found no dividend yield history for this company